KioMedinevsone is intended for adults experiencing symptoms related to knee osteoarthritis, such as pain, reduced mobility, or joint stiffness. If these symptoms sound familiar, speak with your doctor. Only a healthcare professional can assess whether this treatment is appropriate for your condition.
Welcome to the official Kiomedine® website
A new Belgian alternative for knee osteoarthritis
KioMedinevsone is a unique medical device developed for the symptomatic treatment of knee osteoarthritis. Designed in Belgium, this fluid implant contains carboxymethyl-chitosan (CM-chitosan), a patented, animal-free molecule extracted from button mushrooms. This exclusive technology combines lubrication, reduced joint friction, and protection of the synovial fluid to help improve the quality of life for patients living with knee osteoarthritis.
KioMedinevsone is a medical device that must be prescribed and administered by an authorized healthcare professional.
Under treatment
What to do after receiving a KioMedinevsone injection
Rest: Avoid intense physical activity or carrying heavy loads for 48 hours after receiving the KioMedinevsone injection. It is recommended to gradually resume using the treated knee and to engage in regular physical exercise. Staying active is important to maintain joint health and may even help slow the progression of osteoarthritis. It strengthens the muscles supporting the knee while helping to preserve flexibility.
Symptoms to monitor: Contact your doctor if you experience persistent pain, significant inflammation, or any unusual symptoms.
